FDA approves Flonase allergy relief for sale over-the-counter in the United States

-No. 1 prescribed allergy treatment ingredient to be available OTC Thursday 24th July, 2014 GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1  prescribed allergy treatment ingredient1, as an over-the-counter (OTC) treatment for temporary relief of the symptoms of hay fever or …